DIAGNOS Inc.
DGNOF · OTC
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Market Cap | $25,781 | $19,694 | $24,464 | $17,618 |
| - Cash | $89 | $219 | $297 | $359 |
| + Debt | $3,072 | $3,186 | $2,305 | $472 |
| Enterprise Value | $28,764 | $22,660 | $26,471 | $17,730 |
| Revenue | $104 | $170 | $439 | $267 |
| % Growth | -39% | -61.2% | 64.3% | – |
| Gross Profit | -$944 | -$838 | -$418 | -$348 |
| % Margin | -909% | -492.4% | -95.3% | -130.1% |
| EBITDA | -$3,564 | -$2,446 | -$2,101 | -$2,449 |
| % Margin | -3,433.7% | -1,437.6% | -478.7% | -916.8% |
| Net Income | -$4,286 | -$3,121 | -$2,608 | -$2,051 |
| % Margin | -4,129.6% | -1,833.9% | -594.4% | -768.1% |
| EPS Diluted | -0.049 | -0.043 | -0.038 | -0.03 |
| % Growth | -13.3% | -14.4% | -25.8% | – |
| Operating Cash Flow | -$3,637 | -$2,147 | -$1,884 | -$1,357 |
| Capital Expenditures | -$14 | -$11 | -$24 | -$42 |
| Free Cash Flow | -$3,651 | -$2,158 | -$1,908 | -$1,399 |